AMG-317

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAMG-317

Drug Alias NameAnti-IL-4R - AmgenAnti-interleukin-4 receptor antibody - AmgenAMG-317

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionInterleukin-13 inhibitorsAnti-IL13Interleukin-4 receptor subunit alpha inhibitors

TargetsInterleukin-4 receptor subunit alphaInterleukin-13

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A